Oric Pharmaceuticals
ORIC
ORIC
140 hedge funds and large institutions have $947M invested in Oric Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1.98% less ownership
Funds ownership: 111.52% → 109.53% (-2%)
2% less funds holding
Funds holding: 143 → 140 (-3)
16% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 51
Holders
140
Holding in Top 10
12
Calls
$10.5M
Puts
$103K
Top Buyers
| 1 | +$45.8M | |
| 2 | +$34.7M | |
| 3 | +$28.9M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$19.5M |
| 5 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$19.1M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$13.8M | |
| 3 | -$11.2M | |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$9.67M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.73M |
